Deferasirox Accord 360 mg, Filmtabletten - 30 Swissmedic Key 67517005 Registration Holder Accord Healthcare AG Name Deferasirox Accord 360 mg, Filmtabletten Date of registration 01.02.2021 Original/Generic Generic Introduction of Sequence 01.02.2021 ATC-Classification Deferasirox (V03AC03) Revision date WHO WHO-DDD Valid until 31.01.2026 Index Therapeuticus (BSV) 06.99. Show package size 30 Index Therapeuticus (Swissmedic) 06.99. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 503.67 Limitation Yes Limitation text
Deductible 10 % Consumer price 595.20 Feedback FB GTIN 7680675170050 Medication Code Synthetika Pharmacode Disponibility
Composition deferasiroxum 360 mg, cellulosum microcristallinum, carmellosum natricum conexum, hydroxypropylcellulosum substitutum humile, poloxamerum 188, povidonum K 30, lactosum monohydricum 108.1 mg, silica colloidalis anhydrica, natrii stearylis fumaras, ricini oleum hydrogenatum, Überzug: hypromellosum, propylenglycolum, talcum, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 2.1788 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Deferasirox 360 mg
BAG: Active Agent Dose Deferasirox 360 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hydroxypropylcellulosum Substitutum Humile Hypromellosum Überzug Lactose Monohydrate 108.1 mg Natrii Stearylis Fumaras Poloxamer 188 Povidonum K 30 Pro Compresso Obducto Propylenglycol Ricini Oleum Hydrogenatum Silica Colloidalis Anhydrica Talcum
Source Data was imported : 04.03.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
